Allergy & Asthma Medical Group & Research Center Report issue

Academic/Hospital Phase 2 Phase 4

Organization Overview

First Clinical Trial
2005
NCT00235053
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2024

Timeline

NOW
  • Now

Alternative names

Allergy & Asthma Medical Group & Research Center

Active Ingredients

Drugs in Phase 4 Trials (2)

fluticasone (cutivate) (1 trial)

salmeterol (serevent) (1 trial)

Drugs in Phase 2 Trials (1)

zafirlukast (accolate) (1 trial)

Drugs in Other Trials (1)

ciclesonide (alvesco) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Asthma (Phase 4)

Candidiasis (Phase 4)

Candidiasis, Oral (Phase 4)

Voice Disorders (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 4